Información del artículo
El Texto completo está disponible en PDF
References
[1.]
W.T. Carpenter Jr, J.R. Bustillo, G.K. Thaker, J. Van Os, R.F. Krueger, M.J. Green.
The psychoses: cluster 3 of the proposed meta-structure for DSM-V and ICD-11.
Psychol Med, 39 (2009), pp. 2025-2042
[2.]
P. Lichtenstein, B.H. Yip, C. Bjork, Y. Pawitan, T.D. Cannon, P.F. Sullivan, et al.
Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study.
Lancet, 373 (2009), pp. 234-239
[3.]
E. Kraepelin.
Dementia praecox and paraphrenia.
Trans,
[4.]
E. Bleuler.
Dementia praecox or the group of schizophrenias.
Trans,
[5.]
M.J. Cuesta, V. Peralta.
Current psychopathological issues in psychosis: Towards a phenome-wide scanning approach.
Schizophr Bull, 34 (2008), pp. 587-590
[6.]
J.S. Strauss, W.T. Carpenter Jr, J.J. Bartko.
The diagnosis and understanding of schizophrenia Part III. Speculations on the processes that underlie schizophrenic symptoms and signs.
Schizophr Bull, 11 (1974), pp. 61-69
[7.]
N. Andreasen.
Positive vs negative schizophrenia: a critical evaluation.
Schizophr Bull, 11 (1985), pp. 380-389
[8.]
T.J. Crow.
The two-syndrome concept: origins and current status.
Schizophr Bull, 11 (1985), pp. 471-486
[9.]
W.T. Carpenter, D.W. Heinrichs, A.M.I. Wagman.
Deficit and nondeficit forms of schizophrenia: The concept.
Am J Psychiatry, 145 (1988), pp. 578-583
[10.]
B. Kirkpatrick, R.W. Buchanan, D.E. Ross, W.T. Carpenter.
A separate disease within the syndrome of schizophrenia.
Arch Gen Psychiatry, 58 (2001), pp. 165-171
[11.]
C.R. Lake, N. Hurwitz.
Schizoaffective disorder merges schizophrenia and bipolar disorders as one disease - there is no schizoaffective disorder.
Curr Opin Psychiatry, 20 (2007), pp. 365-379
[12.]
J. Van Os, R.J. Linscott, I. Myin-Germeys, P. Delespaul, L. Krabbendam.
A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder.
Psychol Med, 39 (2009), pp. 179-195
[13.]
W.T. Carpenter, R.W. Buchanan, B. Kirkpatrick, C.A. Tamminga, F. Wood.
Strong inference, theory falsification, and the neuroanatomy of schizophrenia.
Arch Gen Psychiatry, 50 (1993), pp. 825-831
[14.]
W.T. Carpenter, R.W. Buchanan.
Domains of psychopathology relevant to the study of etiology and treatment of schizophrenia.
Schizophrenia: scientific progress, pp. 13-22
[15.]
R.W. Buchanan, W.T. Carpenter.
Domains of psychopathology: an approach to the reduction to heterogeneity in schizophrenia.
J Nerv Ment Dis, 182 (1994), pp. 193-204
[16.]
V. Peralta, M.J. Cuesta.
Clinical models of schizophrenia: a critical approach to competing conceptions.
Psychopathology, 33 (2000), pp. 252-258
[17.]
J.S. Strauss.
Diagnostic models and the nature of psychiatric disorder.
Arch Gen Psychiatry, 29 (1973), pp. 445-449
[18.]
V. Peralta, M.J. Cuesta.
A dimensional and categorical architecture for the classification of psychotic disorders.
World Psychiatry, 6 (2007), pp. 36-37
[19.]
M.J. Cuesta, V. Peralta.
Integrating psychopathological dimensions in functional psychoses: a hierarchical approach.
Schizophr Res, 52 (2001), pp. 215-229
[20.]
R.W. Buchanan, M. Davis, D. Goff, M.F. Green, R.S.E. Keefe, A.C. Leon, et al.
A Summary of the FDA-NIMH-MATRICS Workshop on Clinical Trial Design for Neurocognitive Drugs for Schizophrenia.
Schizophr Bull, 31 (2005), pp. 5-19
[21.]
B. Kirkpatrick, W.S. Fenton, W.T. Carpenter Jr, S.R. Marder.
The NIMH-MATRICS Consensus Statement on Negative Symptoms.
Schizophr Bull, 32 (2006), pp. 214-219
[22.]
W.T. Carpenter Jr.
Clinical constructs and therapeutic discovery.
Schizophr Res, 72 (2004), pp. 69-73
[23.]
W.T. Carpenter, J.I. Koenig.
The evolution of drug development in schizophrenia: past issues and future opportunities.
Neuropsychopharmacology, 33 (2008), pp. 2061-2079
Copyright © 2010. SEP y SEPB